Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cox, C. E.
Right arrow Articles by Carey, L. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cox, C. E.
Right arrow Articles by Carey, L. C.

Annals of Surgical Oncology, Vol 2, Issue 3 201-206, Copyright © 1995 by Society of Surgical Oncology

ARTICLES

Analysis of residual cancer after diagnostic breast biopsy: an argument for fine-needle aspiration cytology

C. E. Cox, D. S. Reintgen, S. V. Nicosia, N. N. Ku, P. Baekey and L. C. Carey
Department of Surgery, University of South Florida College of Medicine, Tampa, USA.

BACKGROUND: Diagnostic breast biopsy (DxBx) requires an effective strategy for successful treatment of breast cancer by lumpectomy or mastectomy. Clearance of margins is required to achieve local control. METHODS: We reviewed 844 malignant diagnostic biopsies. The strategy was to perform DxBx on all nonpalpable lesions and fine-needle aspiration (FNA) on all palpable lesions. When FNA was equivocal, DxBx was performed. After positive DxBx, either the biopsy cavity or FNA-positive breast mass was excised, and margins were documented with touch preparation cytology analysis (TPC) and frozen section (FS) as necessary to achieve negative margins. RESULTS: Outside institutions referred 430 excisional biopsies. Two hundred twenty-five (52.3%) were found to have residual cancer at surgical excision. Our institution performed 414 biopsies: 169 were performed on nonpalpable lesions in which 58% had residual tumor at resection; 245 were diagnosed by FNA of palpable lesions. Residual disease was found in 12 (5%). CONCLUSIONS: Of patients who undergo DxBx, > 50% have residual breast cancer. It is recommended that (a) FNA be performed on all palpable masses or DxBx of nonpalpable masses; when cancer is diagnosed, proceed to surgical excision. (b) When lumpectomy is the option, margins should be reexcised and intraoperatively evaluated with TPC and FS at the time of axillary dissection.


This article has been cited by other articles:


Home page
 JCOHome page
L. A. Newman and H. M. Kuerer
Advances in Breast Conservation Therapy
J. Clin. Oncol., March 10, 2005; 23(8): 1685 - 1697.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
C. E. Cox, B. Furman, N. Stowell, M. Ebert, J. Clark, E. Dupont, A. Shons, C. Berman, J. Beauchamp, M. Gardner, et al.
Radioactive Seed Localization Breast Biopsy and Lumpectomy: Can Specimen Radiographs Be Eliminated?
Ann. Surg. Oncol., November 1, 2003; 10(9): 1039 - 1047.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
R. J. Gray, C. Salud, K. Nguyen, E. Dauway, J. Friedland, C. Berman, E. Peltz, G. Whitehead, and C. E. Cox
Randomized Prospective Evaluation of a Novel Technique for Biopsy or Lumpectomy of Nonpalpable Breast Lesions: Radioactive Seed Versus Wire Localization
Ann. Surg. Oncol., October 1, 2001; 8(9): 711 - 715.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the Society of Surgical Oncology.